Referred to the House Committee on Energy and Commerce.
This bill amends the 21st Century Cures Act to explicitly allow certain federal grants to be used for substance use disorder and overdose prevention activities involving fentanyl and xylazine test strips. It clarifies that such activities may include drugs or devices that are approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act.
Progressives emphasize life-saving harm reduction benefits.
Procedurally simple and narrow; manageable opposition possible from members opposing harm-reduction measures.
This bill amends the 21st Century Cures Act to explicitly allow certain federal grants to be used for substance use disorder and overdose prevention activities involving fentanyl and xylazine test strips.
It clarifies that such activities may include drugs or devices that are approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act.
The text is a narrow statutory clarification of allowable grant uses and does not itself appropriate funds.
Small, technical change with low fiscal impact increases chances, though harm-reduction debate could slow progress.
How solid the drafting looks.
Progressives emphasize life-saving harm reduction benefits.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize life-saving harm reduction benefits.
Likely strongly supportive.
The bill expands harm-reduction options and removes a legal ambiguity limiting grant-funded distribution of test strips.
Supporters will view it as a low-cost, evidence-aligned step to reduce overdose deaths.
Generally favorable but cautious.
The bill is a targeted technical fix to allow grant-funded test strip programs, but centrist voters want evidence, fiscal clarity, and program safeguards.
They will favor monitoring and clear metrics.
Likely skeptical to opposed.
Many conservatives will view this as enabling or normalizing illicit drug use and worry about federal funds indirectly supporting harmful behavior.
Some may accept narrow, well‑guarded harm reduction with strict limits.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Small, technical change with low fiscal impact increases chances, though harm-reduction debate could slow progress.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize life-saving harm reduction benefits.
Small, technical change with low fiscal impact increases chances, though harm-reduction debate could slow progress.
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Test Strip Access Act of 2025.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.